Annual Cash & Cash Equivalents
$35.41 M
+$15.96 M+82.12%
31 December 2023
Summary:
BioLife Solutions annual cash & cash equivalents is currently $35.41 million, with the most recent change of +$15.96 million (+82.12%) on 31 December 2023. During the last 3 years, it has fallen by -$55.00 million (-60.83%). BLFS annual cash & cash equivalents is now -60.83% below its all-time high of $90.40 million, reached on 31 December 2020.BLFS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$23.98 M
+$1.96 M+8.92%
30 September 2024
Summary:
BioLife Solutions quarterly cash and cash equivalents is currently $23.98 million, with the most recent change of +$1.96 million (+8.92%) on 30 September 2024. Over the past year, it has increased by +$4.74 million (+24.65%). BLFS quarterly cash and cash equivalents is now -74.49% below its all-time high of $93.98 million, reached on 30 September 2020.BLFS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLFS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.1% | +24.6% |
| 3 y3 years | -60.8% | -68.1% |
| 5 y5 years | +15.5% | +13.1% |
BLFS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -60.8% | +82.1% | -68.1% | +25.5% |
| 5 y | 5 years | -60.8% | +449.1% | -74.5% | +274.6% |
| alltime | all time | -60.8% | >+9999.0% | -74.5% | >+9999.0% |
BioLife Solutions Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $23.98 M(+8.9%) |
| June 2024 | - | $22.01 M(-25.9%) |
| Mar 2024 | - | $29.69 M(-16.1%) |
| Dec 2023 | $35.41 M(+82.1%) | $35.41 M(+84.1%) |
| Sept 2023 | - | $19.23 M(-10.1%) |
| June 2023 | - | $21.40 M(+12.0%) |
| Mar 2023 | - | $19.11 M(-1.7%) |
| Dec 2022 | $19.44 M(-72.2%) | $19.44 M(-28.1%) |
| Sept 2022 | - | $27.04 M(+12.6%) |
| June 2022 | - | $24.00 M(-59.6%) |
| Mar 2022 | - | $59.46 M(-14.9%) |
| Dec 2021 | $69.86 M(-22.7%) | $69.86 M(-7.0%) |
| Sept 2021 | - | $75.10 M(-1.5%) |
| June 2021 | - | $76.25 M(-14.3%) |
| Mar 2021 | - | $89.01 M(-1.5%) |
| Dec 2020 | $90.40 M(+1302.0%) | $90.40 M(-3.8%) |
| Sept 2020 | - | $93.98 M(+214.5%) |
| June 2020 | - | $29.88 M(+366.9%) |
| Mar 2020 | - | $6.40 M(-0.7%) |
| Dec 2019 | $6.45 M(-79.0%) | $6.45 M(-69.6%) |
| Sept 2019 | - | $21.20 M(+8.1%) |
| June 2019 | - | $19.62 M(-38.4%) |
| Mar 2019 | - | $31.82 M(+3.8%) |
| Dec 2018 | $30.66 M(+360.1%) | $30.66 M(-5.3%) |
| Sept 2018 | - | $32.38 M(+128.6%) |
| June 2018 | - | $14.17 M(+101.4%) |
| Mar 2018 | - | $7.03 M(+5.5%) |
| Dec 2017 | $6.66 M(+374.0%) | $6.66 M(+135.4%) |
| Sept 2017 | - | $2.83 M(+22.3%) |
| June 2017 | - | $2.31 M(+1.1%) |
| Mar 2017 | - | $2.29 M(+62.9%) |
| Dec 2016 | $1.41 M(-35.3%) | $1.41 M(+2.7%) |
| Sept 2016 | - | $1.37 M(+3.8%) |
| June 2016 | - | $1.32 M(-20.7%) |
| Mar 2016 | - | $1.66 M(-23.5%) |
| Dec 2015 | $2.17 M(-14.4%) | $2.17 M(-7.6%) |
| Sept 2015 | - | $2.35 M(-39.6%) |
| June 2015 | - | $3.90 M(+31.1%) |
| Mar 2015 | - | $2.97 M(+17.1%) |
| Dec 2014 | $2.54 M(+1524.3%) | $2.54 M(-22.5%) |
| Sept 2014 | - | $3.28 M(-44.5%) |
| June 2014 | - | $5.90 M(-54.0%) |
| Mar 2014 | - | $12.84 M(+8114.7%) |
| Dec 2013 | $156.30 K(-20.5%) | $156.30 K(+97.1%) |
| Sept 2013 | - | $79.30 K(+4.1%) |
| June 2013 | - | $76.20 K(+23.9%) |
| Mar 2013 | - | $61.50 K(-68.7%) |
| Dec 2012 | $196.50 K(+1062.7%) | $196.50 K(+2520.0%) |
| Sept 2012 | - | $7500.00(-95.2%) |
| June 2012 | - | $155.40 K(+120.4%) |
| Mar 2012 | - | $70.50 K(+317.2%) |
| Dec 2011 | $16.90 K(+428.1%) | $16.90 K(-15.9%) |
| Sept 2011 | - | $20.10 K(-44.3%) |
| June 2011 | - | $36.10 K(+2.8%) |
| Mar 2011 | - | $35.10 K(+996.9%) |
| Dec 2010 | $3200.00(-97.7%) | $3200.00(+966.7%) |
| Sept 2010 | - | $300.00(-99.6%) |
| June 2010 | - | $67.90 K(+2852.2%) |
| Mar 2010 | - | $2300.00(-98.3%) |
| Dec 2009 | $139.20 K(+41.0%) | $139.20 K(+45.3%) |
| Sept 2009 | - | $95.80 K(+10.9%) |
| June 2009 | - | $86.40 K(-79.8%) |
| Mar 2009 | - | $428.20 K(+333.8%) |
| Dec 2008 | $98.70 K | $98.70 K(+16.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2008 | - | $85.10 K(-3.0%) |
| June 2008 | - | $87.70 K(-35.6%) |
| Mar 2008 | - | $136.20 K(+141.1%) |
| Dec 2007 | $56.50 K(-52.4%) | $56.50 K(-92.5%) |
| Sept 2007 | - | $754.40 K(+6.7%) |
| June 2007 | - | $707.10 K(+144.9%) |
| Mar 2007 | - | $288.70 K(+143.2%) |
| Dec 2006 | $118.70 K(-35.9%) | $118.70 K(-75.4%) |
| Sept 2006 | - | $483.00 K(-23.3%) |
| June 2006 | - | $629.90 K(+1938.5%) |
| Mar 2006 | - | $30.90 K(-83.3%) |
| Dec 2005 | $185.10 K(-65.2%) | $185.10 K(-39.5%) |
| Sept 2005 | - | $305.80 K(+61.5%) |
| June 2005 | - | $189.40 K(-47.6%) |
| Mar 2005 | - | $361.40 K(-32.0%) |
| Dec 2004 | $531.70 K(-32.5%) | $531.70 K(-7.0%) |
| Sept 2004 | - | $571.80 K(-21.1%) |
| June 2004 | - | $724.30 K(-17.9%) |
| Mar 2004 | - | $882.70 K(+12.0%) |
| Dec 2003 | $787.90 K(+1074.2%) | $787.90 K(>+9900.0%) |
| Sept 2003 | - | $2700.00(-82.4%) |
| June 2003 | - | $15.30 K(-85.4%) |
| Mar 2003 | - | $104.60 K(+55.9%) |
| Dec 2002 | $67.10 K(-76.5%) | $67.10 K(-75.4%) |
| Sept 2002 | - | $273.10 K(-86.2%) |
| June 2002 | - | $1.97 M(+1526.1%) |
| Mar 2002 | - | $121.30 K(-57.6%) |
| Dec 2001 | $286.10 K(-86.7%) | $286.10 K(-19.1%) |
| Sept 2001 | - | $353.50 K(+182.3%) |
| June 2001 | - | $125.20 K(-88.5%) |
| Mar 2001 | - | $1.09 M(-49.5%) |
| Dec 2000 | $2.15 M(>+9900.0%) | $2.15 M(-33.0%) |
| Sept 2000 | - | $3.21 M(-39.2%) |
| June 2000 | - | $5.29 M(>+9900.0%) |
| Mar 2000 | - | $29.30 K(-78.3%) |
| Dec 1999 | $8000.00(-94.1%) | - |
| Dec 1998 | $135.20 K(+9.0%) | $135.20 K(+9.0%) |
| Dec 1997 | $124.00 K(-93.0%) | $124.00 K(-38.0%) |
| Sept 1997 | - | $200.00 K(-75.0%) |
| June 1997 | - | $800.00 K(-46.7%) |
| Mar 1997 | - | $1.50 M(-40.0%) |
| Dec 1996 | $1.77 M(+41.4%) | - |
| Sept 1996 | - | $2.50 M(+99.9%) |
| June 1996 | - | $1.25 M(-3.8%) |
| June 1996 | $1.25 M(+11.9%) | - |
| Mar 1996 | - | $1.30 M(+85.7%) |
| Dec 1995 | - | $700.00 K(-36.4%) |
| Sept 1995 | - | $1.10 M(-1.6%) |
| June 1995 | $1.12 M(-53.4%) | $1.12 M(-25.5%) |
| Mar 1995 | - | $1.50 M(-37.5%) |
| Sept 1994 | - | $2.40 M(0.0%) |
| June 1994 | $2.40 M(+20.0%) | $2.40 M(+140.0%) |
| Mar 1994 | - | $1.00 M(-37.5%) |
| Dec 1993 | - | $1.60 M(-36.0%) |
| Sept 1993 | - | $2.50 M(+25.0%) |
| June 1993 | $2.00 M(-13.0%) | $2.00 M(+11.1%) |
| Mar 1993 | - | $1.80 M(-5.3%) |
| Dec 1992 | - | $1.90 M(+46.2%) |
| Sept 1992 | - | $1.30 M(-43.5%) |
| June 1992 | $2.30 M(-55.8%) | $2.30 M(+155.6%) |
| Dec 1991 | - | $900.00 K(-82.7%) |
| June 1991 | $5.20 M(+126.1%) | $5.20 M(+92.6%) |
| Sept 1990 | - | $2.70 M(+17.4%) |
| June 1990 | $2.30 M(+475.0%) | $2.30 M(+475.0%) |
| June 1989 | $400.00 K | $400.00 K |
FAQ
- What is BioLife Solutions annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioLife Solutions?
- What is BioLife Solutions annual cash & cash equivalents year-on-year change?
- What is BioLife Solutions quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BioLife Solutions?
- What is BioLife Solutions quarterly cash and cash equivalents year-on-year change?
What is BioLife Solutions annual cash & cash equivalents?
The current annual cash & cash equivalents of BLFS is $35.41 M
What is the all time high annual cash & cash equivalents for BioLife Solutions?
BioLife Solutions all-time high annual cash & cash equivalents is $90.40 M
What is BioLife Solutions annual cash & cash equivalents year-on-year change?
Over the past year, BLFS annual cash & cash equivalents has changed by +$15.96 M (+82.12%)
What is BioLife Solutions quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BLFS is $23.98 M
What is the all time high quarterly cash and cash equivalents for BioLife Solutions?
BioLife Solutions all-time high quarterly cash and cash equivalents is $93.98 M
What is BioLife Solutions quarterly cash and cash equivalents year-on-year change?
Over the past year, BLFS quarterly cash and cash equivalents has changed by +$4.74 M (+24.65%)